Research and Clinical Trials
Emergency care and effective treatment are essential for avoiding long-term damage or death from a stroke. Physicians on the medical staff at CDH who treat patients at the Neurosciences Institute at CDH are actively participating in national clinical trials focused on the treatment of acute stroke. Current clinical trials are aiding interventional neuroradiologists in extending the typical three-hour treatment window for acute stroke to six, eight and even ten hours.
Current clinical trials being offered at CDH in the areas of stroke treatment areas include:
One of the goals of the CDH Epilepsy Program is to improve treatments for epilepsy. In many cases existing treatments cannot control an individual's seizures or do so with an unacceptable level of side effects. New anti-epileptic medications, which are not yet on the market, may be offered to patients through clinical trials. Some of these medications may prove useful for individuals with seizures. Participation in clinical trials of new anti-epileptic medications may provide treatment years before it would otherwise be available.
How to Contact Us
For more information about research and clinical trials, please call 630-933-6107 or 877-79BRAIN (877-792-7246).
To view a list of current clinical trials, please click here.